In human breast cancer cells (MCF-7), IGF-I potently induced expression of IGFBP-2 (46) and E2 enhanced the effect of IGF-I with its basal activity being on a lower level if compared to IGF-I (47). The gene discussed is IGF1; the disease is breast carcinoma.